These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7628402)

  • 1. Modulation of osteogenic cell ultrastructure by RS-23581, an analog of human parathyroid hormone (PTH)-related peptide-(1-34), and bovine PTH-(1-34).
    Leaffer D; Sweeney M; Kellerman LA; Avnur Z; Krstenansky JL; Vickery BH; Caulfield JP
    Endocrinology; 1995 Aug; 136(8):3624-31. PubMed ID: 7628402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats.
    Kimmel DB; Bozzato RP; Kronis KA; Coble T; Sindrey D; Kwong P; Recker RR
    Endocrinology; 1993 Apr; 132(4):1577-84. PubMed ID: 8462456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893.
    Stewart AF; Cain RL; Burr DB; Jacob D; Turner CH; Hock JM
    J Bone Miner Res; 2000 Aug; 15(8):1517-25. PubMed ID: 10934650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human parathyroid hormone-(1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats.
    Liu CC; Kalu DN
    J Bone Miner Res; 1990 Sep; 5(9):973-82. PubMed ID: 2281827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity.
    Iida-Klein A; Lu SS; Cosman F; Lindsay R; Dempster DW
    Bone; 2007 Feb; 40(2):391-8. PubMed ID: 17056311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats.
    Wronski TJ; Ratkus AM; Thomsen JS; Vulcan Q; Mosekilde L
    J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic bone formation with weekly PTH administration in ovariectomized rats.
    Gittens SA; Wohl GR; Zernicke RF; Matyas JR; Morley P; Uludag H
    J Pharm Pharm Sci; 2004 Jan; 7(1):27-37. PubMed ID: 15144732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid hormone (1-34) increased total body bone mass in aged female rats.
    Simmons HA; Pirie CM; Thompson DD; Ke HZ
    J Pharmacol Exp Ther; 1998 Jul; 286(1):341-4. PubMed ID: 9655878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
    Iwaniec UT; Mosekilde L; Mitova-Caneva NG; Thomsen JS; Wronski TJ
    Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats.
    Ma Y; Jee WS; Chen Y; Gasser J; Ke HZ; Li XJ; Kimmel DB
    J Bone Miner Res; 1995 Nov; 10(11):1726-34. PubMed ID: 8592950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the anabolic effects of synthetic parathyroid hormone-related protein (PTHrP) 1-34 and PTH 1-34 on bone in rats.
    Hock JM; Fonseca J; Gunness-Hey M; Kemp BE; Martin TJ
    Endocrinology; 1989 Oct; 125(4):2022-7. PubMed ID: 2791976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human parathyroid hormone-(1-34) increases bone mass in ovariectomized and orchidectomized rats.
    Hock JM; Gera I; Fonseca J; Raisz LG
    Endocrinology; 1988 Jun; 122(6):2899-904. PubMed ID: 3371266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells.
    Dobnig H; Turner RT
    Endocrinology; 1995 Aug; 136(8):3632-8. PubMed ID: 7628403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RS-66271, a C-terminally substituted analog of human parathyroid hormone-related protein (1-34), increases trabecular and cortical bone in ovariectomized, osteopenic rats.
    Vickery BH; Avnur Z; Cheng Y; Chiou SS; Leaffer D; Caulfield JP; Kimmel DB; Ho T; Krstenansky JL
    J Bone Miner Res; 1996 Dec; 11(12):1943-51. PubMed ID: 8970897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of skeletally mature ovariectomized rhesus monkeys with PTH(1-84) for 16 months increases bone formation and density and improves trabecular architecture and biomechanical properties at the lumbar spine.
    Fox J; Miller MA; Newman MK; Turner CH; Recker RR; Smith SY
    J Bone Miner Res; 2007 Feb; 22(2):260-73. PubMed ID: 17087625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of parathyroid hormone and parathyroid hormone fragments on the intracellular ionized calcium concentration in an osteoblast cell line.
    van Leeuwen JP; Bos MP; Löwik CW; Herrmann-Erlee MP
    Bone Miner; 1988 Jun; 4(2):177-88. PubMed ID: 3142533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats.
    Meng XW; Liang XG; Birchman R; Wu DD; Dempster DW; Lindsay R; Shen V
    J Bone Miner Res; 1996 Apr; 11(4):421-9. PubMed ID: 8992872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats.
    Wronski TJ; Yen CF; Qi H; Dann LM
    Endocrinology; 1993 Feb; 132(2):823-31. PubMed ID: 8425497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of the receptor for parathyroid hormone (PTH) and PTH-related peptide by PTH in primary fetal rat osteoblasts.
    Jongen JW; Willemstein-van Hove EC; van der Meer JM; Bos MP; Jüppner H; Segre GV; Abou-Samra AB; Feyen JH; Herrmann-Erlee MP
    J Bone Miner Res; 1996 Sep; 11(9):1218-25. PubMed ID: 8864895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.